medigraphic.com
ISSN 2500-7106 (Digital)
ISSN 0123-2576 (Impreso)
Medicina & Laboratorio

2008, Número 11-12

<< Anterior

Medicina & Laboratorio 2008; 14 (11-12)


Manual de bioseguridad en el laboratorio

Idioma: Español
Referencias bibliográficas: 57
Paginas: 557-588
Archivo PDF: 693.13 Kb.


FRAGMENTO

Los primeros auxilios consisten en la aplicación experta de principios aceptados de tratamiento médico en el momento y el lugar en que se produce un accidente. Es el método aprobado para tratar a la víctima de un accidente hasta que se la pueda poner en manos de un médico para el tratamiento definitivo de la lesión. El equipo mínimo de primeros auxilios consta de un botiquín, ropa protectora y equipo de seguridad para la persona que presta los primeros auxilios, y equipo para la irrigación ocular.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Safety in health-care laboratories. Geneva, World Health Organization, 1997, (http://1. whqlibdoc.who.int/hq/1997/WHO_LAB_97.1.pdf).

  2. Garner JS, Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. American Journal of Infection Control, 1996, 24:24–52, (http://www.cdc.gov/ncidod/hip/isolat/isolat.htm).

  3. Hunt GJ, Tabachnick WJ.Handling small arbovirus vectors safely during biosafety level 3 3. containment: Culicoides variipennis sonorensis (Diptera: Ceratopogonidae) and exotic bluetongue viruses. Journal of Medical Entomology, 1996, 33:271–277.

  4. National Research Council. Occupational health and safety in the care and use of research animals.Washington, DC, National Academy Press, 1997.

  5. Richmond JY, Quimby F. Considerations for working safely with infectious disease agents in research animals. In: Zak O, Sande MA, eds. Handbook of animal models of infection. London, Academic Press, 1999:69–74.

  6. Biosafety in microbiological and biomedical laboratories, 4th ed. Washington, DC, United States Department of Health and Human Services/Centers for Disease Control and Preven-tion/National Institutes of Health, 1999.

  7. Class II (laminar flow) biohazard cabinetry. Ann Arbor, MI, National Sanitation Foundation, 2002 (NSF/ANSI 49–2002).

  8. Richmond JY,McKinney RW. Primary containment for biohazards: selection, installation and use of biological safety cabinets, 2nd ed.Washington, DC, United States Department of Health and Human Services/Centers for Disease Control and Prevention/National Institutes of Health, 2000.

  9. Microbiological safety cabinets. Recommendations for information to be exchanged bet-ween purchaser, vendor and installer and recommendations for installation. London, Bri-tish Standards Institution, 1992 (Standard BS 5726–2:1992).

  10. Microbiological safety cabinets. Recommendations for selection, use and maintenance. London, British Standards Institution, 1992 (Standard BS 5726–4:1992).

  11. Biological containment cabinets (Class I and II): installation and field testing. Toronto, Ca-nadian Standards Association, 1995 (Standard Z316.3–95 (R2000)).

  12. Collins CH, Kennedy DA. Laboratory acquired infections: history, incidence, causes and prevention, 4th ed. Oxford, Butterworth-Heinemann, 1999.

  13. Health Canada. Laboratory biosafety manual, 2nd ed. Ottawa, Minister of Supply and Services Canada, 1996.

  14. Biological safety cabinets – biological safety cabinets (Class I) for personnel and environment protection. Sydney, Standards Australia International, 1994 (Standard AS 2252.1–1994).

  15. Biological safety cabinets – laminar flow biological safety cabinets (Class II) for person-nel, environment and product protection. Sydney, Standards Australia International, 1994 (Standard AS 2252.2–1994).

  16. Standards Australia/Standards New Zealand. Biological safety cabinets – installation and use. Sydney, Standards Australia International, 2000 (Standard AS/NZS 2647:2000).

  17. Advisory Committee on Dangerous Pathogens. Guidance on the use, testing and mainte-nance of laboratory and animal flexible film isolators. London, Health and Safety Executive, 1990.

  18. Standards Australia/Standards New Zealand. Safety in laboratories – microbiological as-pects and containment facilities. Sydney, Standards Australia International, 2002 (Standard AS/NZS 2243.3:2002).

  19. Centers for Disease Control and Prevention. Recommendations for prevention of HIV transmission in health-care settings. Morbidity and Mortality Weekly Report, 1987, 36 (Su-ppl. 2):1S–18S.

  20. Bosque PJ et al. Prions in skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America, 2002, 99:3812–3817.

  21. Bartz JC, Kincaid AE, Bessen RA. Rapid prion neuroinvasion following tongue infection. Journal of Virology, 2003, 77:583–591.

  22. Thomzig A et al. Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie. EMBO Reports, 2003, 4:530–533.

  23. Glatzel M et al. Extraneural pathologic prion protein in sporadic Creutzfeldt- Jakob disease. New England Journal of Medicine, 2003, 349:1812–1820.

  24. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infec-tivity in formalin-fixed tissue samples from patients with Creutzfeldt- Jakob disease. Neuro-logy, 1990, 40:887–890.

  25. Taylor DM et al. The effect of formic acid on BSE and scrapie infectivity in fixed and unfixed brain-tissue. Veterinary Microbiology, 1997, 58:167–174.

  26. Safar J et al. Prions. In: Richmond JY, McKinney RW, eds. Biosafety in microbiological and biomedical laboratories, 4th ed.Washington, DC, United States Department of Health and Human Services, 1999:134–143.

  27. Bellinger-Kawahara C et al. Purified scrapie prions resist inactivation by UV irradiation. Journal of Virology, 1987, 61:159–166.

  28. Health Services Advisory Committee. Safe working and the prevention of infection in clini-cal laboratories. London, HSE Books, 1991.

  29. Russell AD, Hugo WB, Ayliffe GAJ. Disinfection, preservation and sterilization, 3rd ed. Oxford, Blackwell Scientific, 1999.

  30. Ascenzi JM. Handbook of disinfectants and antiseptics. New York, NY, Marcel Dekker, 1996.

  31. Block SS. Disinfection, sterilization & preservation, 5th ed. Philadelphia, PA, Lippincott Williams & Wilkins, 2001.

  32. Rutala WA. APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epide-miology, INC. American Journal of Infection Control, 1996, 24:313–342.

  33. Sattar SA, Springthorpe VS, Rochon M. A product based on accelerated and stabilized hydrogen peroxide: evidence for broad-spectrum germicidal activity. Canadian Journal of Infection Control, 1998, 13:123–130.

  34. Schneider PM. Emerging low temperature sterilization technologies. In: Rutala WA, eds.Disinfection & sterilization in health care. Champlain, NY, Polyscience, 1997:79–92.

  35. Springthorpe VS. New chemical germicides. In: Rutala WA, eds. Disinfection & sterilization in health care. Champlain, NY, Polyscience, 1997:273–280.

  36. Steelman VM. Activity of sterilization processes and disinfectants against prions. In: Rutala WA, eds.Disinfection & sterilization in health care. Champlain, NY, Polyscience, 1997:255–271.

  37. Taylor DM. Transmissible degenerative encephalopathies: inactivation of the unconventio-nal causal agents. In: Russell AD, Hugo WB, Ayliffe GAJ, eds. Disinfection, preservation and sterilization, 3rd ed. Oxford, Blackwell Scientific, 1999:222–236.

  38. Infection control guidelines for hand washing, cleaning, disinfection and sterilization in health care, 2nd ed. Ottawa, Laboratory Centre for Disease Control, Health Canada, 1998.

  39. Springthorpe VS, Sattar SA.Chemical disinfection of virus-contaminated surfaces. CRC Cri-tical Reviews in Environmental Control, 1990, 20:169–229.

  40. Recommendations on the transport of dangerous goods, 13th revised edition, New York and Geneva, United Nations, 2003, (http://www.unece.org/trans/danger/ publi/unrec/rev13/13files_e.html).

  41. Technical instructions for the safe transport of dangerous goods by air, 2003–2004 Edition. Montreal, International Civil Aviation Organization, 2002.

  42. Economic Commission for Europe Inland Transport Committee. Restructured ADR appli-cable as from 1 January 2003. New York and Geneva, United Nations, 2002, (http://www.unece.org/trans/danger/publi/adr/adr2003/ ContentsE.html).

  43. Infectious substances shipping guidelines. Montreal, International Air Transport Association, 2003, (http://www.iata.org/ads/issg.htm).

  44. Transport of Infectious Substances. Geneva, World Health Organization, 2004, (http://www.who.int/csr/resources/publications/WHO_CDS_CSR_LYO_2004_9/ en/).

  45. Berg P et al. Asilomar conference on recombinant DNA molecules. Science, 1975, 188:991–994.

  46. European Council. Council Directive 98/81/EC of 26 October 1998 amending Directive 90/219/EEC on the contained use of genetically modified microorganisms. Official Journal, 1998, L330:13–31.

  47. O’Malley BW Jr et al. Limitations of adenovirus-mediated interleukin-2 gene therapy for oral cancer. Laryngoscope, 1999, 109:389–395.

  48. World Health Organization. Maintenance and distribution of transgenic mice susceptible to human viruses: memorandum from a WHO meeting. Bulletin of the World Health Or-ganization, 1993, 71:497–502.

  49. Furr AK. CRC handbook of laboratory safety, 5th ed. Boca Raton, FL, CRC Press, 2000.

  50. Lenga RE. The Sigma-Aldrich Library of Chemical Safety Data, 2nd ed.Milwakee, WI, Al-drich Chemical Company, 1988.

  51. Lewis RJ. Sax’s dangerous properties of industrial materials, 10th ed. Toronto, John Wiley and Sons, 1999.




2020     |     www.medigraphic.com